Takeda appoints new Area Head for India, CIS, Middle East, Turkey and Africa
Dr Mahender Nayak will continue to increase patient access to Takeda’s portfolio of highly innovative medicines
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Takeda
Takeda expands India portfolio of rare disease therapies
Company launches enzyme replacement therapy bouquet for Lysosomal Storage Disorders (LSD), Idursulfase for Hunter Syndrome,…
Takeda’s dengue vaccine candidate demonstrates protection in children aged four to 16 years,…
Takeda’s dengue vaccine candidate was generally well-tolerated, and no important safety risks have been observed to date
Stada buys Takeda drug bundle to boost Russia business
The portfolio, which Takeda is selling in a push to slash debt after its $59 billion purchase of Shire, includes drugs sold…